News
Our lives are filled with binary decisions—choices between one of two alternatives. But what's really happening inside our ...
In a perspective, Northwestern Engineering’s Chad Mirkin and Milan Mrksich argue that structural precision drives therapeutic ...
RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...
Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...
This useful study reports a method to detect and analyze a novel post-translational modification, lysine acetoacetylation (Kacac), finding it regulates protein metabolism pathways. The study unveils ...
A new study published in Genetics in Medicine identifies a novel disease-associated gene, GPKOW, that plays an important role ...
Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...
The identification and intervention of Alzheimer's Disease (AD) in its early-stage allows for the timely implementation of lifestyle modifications and therapeutic strategies. Although dysregulation of ...
In the default model, the graph representing each individual enhancer can be arbitrarily complicated. To show how the ABC Score formula can arise from the default model, we need to impose the further ...
showing that Dsc2 mRNA injections temporarily prevented disease progression and restored heart function in Dsc2-deficient mice, and also had promising therapeutic effects in the transverse aortic ...
Departments of Cardiology, Fudan University, Shanghai, China. (Y. Zou, Z.L., J.J., Q.L., J.M.J.W., K.J., X.R., Y. Zhang, C.H., Y.X., H.G., J. Lin, J.G., Y.D ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results